Currently, the most important PCa screening tools are based on the evaluation of prostate specific antigen levels and digital rectal examination (DRE), being both considered of limited accuracy in establishing a disease-specific diagnosis (1, 2), and occasionally leading to.
The NIDDK translates and disseminates research findings to increase knowledge and understanding about health and disease among patients, health professionals, and the public. Currently, the most important PCa screening tools are based on the evaluation of prostate specific antigen levels and digital rectal examination (DRE), being both considered of limited accuracy in establishing a disease-specific diagnosis (1,2), and occasionally leading to.